Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

@article{Worm2010RiskOM,
  title={Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.},
  author={Signe Westring Worm and Caroline Sabin and Rainer K. Weber and Peter Reiss and Wafaa M El-Sadr and François Dabis and St{\'e}phane De Wit and Matthew G. Law and Antonella d'Arminio Monforte and Nina Friis-M\oller and Ole Kirk and Eric Fontas and Ian Weller and Andrew N Phillips and Jens D. Lundgren},
  journal={The Journal of infectious diseases},
  year={2010},
  volume={201 3},
  pages={318-30}
}
BACKGROUND. The risk of myocardial infarction (MI) in patients with human immunodeficiency virus (HIV) infection has been assessed in 13 anti-HIV drugs in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. METHODS. Poisson regression models were adjusted for cardiovascular risk factors, cohort, calendar year, and use of other antiretroviral drugs and assessed the association between MI risk and cumulative (per year) or recent (current or in the past 6 months) use of… CONTINUE READING
Highly Influential
This paper has highly influenced 16 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS